The largest increases were seen in low-income and middle-income countries in southeast Asia, south Asia, the Middle East and north Africa, and Latin America and the Caribbean. The country with the ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Biomedical scientist Dr Judey Pretorius explains the close link between diabetes and skin problems. She says high blood sugar ...

The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.